Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiancheng Li

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Parkinson'S Disease|February 16, 2026
The Use of a Digital Social Forum in a Parkinson's Disease Risk Cohort: A Thematic Analysis of Forum MessagesLaura J Smith, Janusiya Jeyaganesh, Xiancheng Li, et al.
Oncology Reports|December 22, 2023
[Retracted] Isoquercitrin inhibits bladder cancer progression <i>in vitro</i> and <i>in vivo</i> by regulating the PI3K/Akt and PKC signaling pathwaysFeng Chen, Xiaochi Chen, Deyong Yang, et al.
Oncology Reports|May 14, 2016
Isoquercitrin inhibits bladder cancer progression in vivo and in vitro by regulating the PI3K/Akt and PKC signaling pathwaysFeng Chen, Xiaochi Chen, Deyong Yang, et al.
Oncology Letters|December 1, 2016
Low extracellular lysyl oxidase expression is associated with poor prognosis in patients with prostate cancerWei Zheng, Xuejian Wang, Qiwei Chen, et al.
Pharmacological Research|May 1, 2021
Profibrotic mechanisms of DPP8 and DPP9 highly expressed in the proximal renal tubule epithelial cellsYuzhan Zhang, Ke Li, Yan Li, et al.
Molecular Oncology|September 2, 2022
Analysis of genetic profiling, pathomics signature, and prognostic features of primary lymphoepithelioma-like carcinoma of the renal pelvisBo Fan, Yuanbin Huang, Hongshuo Zhang, et al.
Plos One|April 4, 2017
Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classificationShimeng Fang, Hongzhu Tian, Xiancheng Li, et al.
Frontiers in Immunology|August 7, 2025
Integrating clinical trial landscapes and bibliometric analysis: unveiling the impact of PD-1/PD-L1 inhibitors on renal cell carcinoma research and therapeutic trajectories summaryYuanbin Huang, Xinmiao Ma, Hengxing Zhu, et al.
Medicine|May 20, 2021
Can bipolar transurethral enucleation of the prostate be a better alternative to the bipolar transurethral resection of the prostate?: A prospective comparative studyMohammed Abdulwahab Al-Radhi, Lo Ka Lun, Mohammed Safi, et al.
International Journal of Oncology|December 3, 2019
MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathwayBo Fan, Yiying Jin, Hongshuo Zhang, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Parkinson'S Disease|February 16, 2026
The Use of a Digital Social Forum in a Parkinson's Disease Risk Cohort: A Thematic Analysis of Forum MessagesLaura J Smith, Janusiya Jeyaganesh, Xiancheng Li, et al.
Oncology Reports|December 22, 2023
[Retracted] Isoquercitrin inhibits bladder cancer progression <i>in vitro</i> and <i>in vivo</i> by regulating the PI3K/Akt and PKC signaling pathwaysFeng Chen, Xiaochi Chen, Deyong Yang, et al.
Oncology Reports|May 14, 2016
Isoquercitrin inhibits bladder cancer progression in vivo and in vitro by regulating the PI3K/Akt and PKC signaling pathwaysFeng Chen, Xiaochi Chen, Deyong Yang, et al.
Oncology Letters|December 1, 2016
Low extracellular lysyl oxidase expression is associated with poor prognosis in patients with prostate cancerWei Zheng, Xuejian Wang, Qiwei Chen, et al.
Pharmacological Research|May 1, 2021
Profibrotic mechanisms of DPP8 and DPP9 highly expressed in the proximal renal tubule epithelial cellsYuzhan Zhang, Ke Li, Yan Li, et al.
Molecular Oncology|September 2, 2022
Analysis of genetic profiling, pathomics signature, and prognostic features of primary lymphoepithelioma-like carcinoma of the renal pelvisBo Fan, Yuanbin Huang, Hongshuo Zhang, et al.
Plos One|April 4, 2017
Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classificationShimeng Fang, Hongzhu Tian, Xiancheng Li, et al.
Frontiers in Immunology|August 7, 2025
Integrating clinical trial landscapes and bibliometric analysis: unveiling the impact of PD-1/PD-L1 inhibitors on renal cell carcinoma research and therapeutic trajectories summaryYuanbin Huang, Xinmiao Ma, Hengxing Zhu, et al.
Medicine|May 20, 2021
Can bipolar transurethral enucleation of the prostate be a better alternative to the bipolar transurethral resection of the prostate?: A prospective comparative studyMohammed Abdulwahab Al-Radhi, Lo Ka Lun, Mohammed Safi, et al.
International Journal of Oncology|December 3, 2019
MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathwayBo Fan, Yiying Jin, Hongshuo Zhang, et al.
Pageof 6